SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CuraGen (CRGN)
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
478 35 0 CRGN
Emcee:  Superhawk Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
378CuraGen Reports Fourth Quarter and Year End 2004 Financial Results and 2005 Projnigel bates-2/3/2005
377CuraGen and TopoTarget Advance PXD101 into Phase II Clinical Program Tuesday Febnigel bates-2/1/2005
376Pipeline to profits Maria Garriga , New Haven Register Staff 01/09/2005 BRAJim Oravetz-1/11/2005
375Slick.keokalani'nui-12/21/2004
374>>BRANFORD, Conn., Dec. 20 /PRNewswire-FirstCall/ -- 454 Life Sciences, a tuck-12/21/2004
373[FGF-20 is implicated in cancer and development] >>EMBO J. 2004 Dec 09; [tuck-12/16/2004
372Single Dose Phase I Data on CG53135 for the Prevention of Oral Mucositis Presentnigel bates-12/5/2004
371CuraGen Receives Fast Track Designation for CG53135 December 02, 2004 06:30:00sjemmeri-12/2/2004
370[FGF7 - an inhibitor of phosphate transport] >>J Clin Endocrinol Metab. 2tuck-11/30/2004
369CuraGen Receives Orphan Drug Designation from the FDA for CR002 in IgA Nephropatnigel bates-11/11/2004
368CuraGen Reports Third Quarter 2004 Financial Results Thursday October 28, 6:31 anigel bates-10/28/2004
367CuraGen and Bayer Advance Investigational Compound for Diabetes to Preclinical Pnigel bates-10/26/2004
366CuraGen Details Clinical Development Plan for CG53135 and CR002 at Rodman & nigel bates-10/26/2004
365CuraGen lays off 110 from 3 offices 10/20/2004 Steve Higgins , New Haven RegiJim Oravetz-10/20/2004
364I'm sorry, but for the record...today's date is October 14, 2004. Now lkeokalani'nui-10/14/2004
363>>NEW HAVEN, Conn., Oct. 13 /PRNewswire-FirstCall/ -- CuraGen Corporation tuck-10/13/2004
362Not sure how relevant this is, or what it means . . . maybe a side effect istuck-10/13/2004
361>>NEW HAVEN, Conn., Oct. 7 /PRNewswire-FirstCall/ -- CuraGen Corporation (tuck-10/7/2004
360CuraGen and TopoTarget Announce Collaboration with the National Cancer Institutenigel bates-8/24/2004
359Genomics Concerns Stage a Comeback GENE MACHINES DAVID P. HAMILTON Companies RJim Oravetz-8/6/2004
358CuraGen and TopoTarget Initiate Phase I Trial of PXD101 in Patients with Hematolnigel bates-6/30/2004
357>>THOUSAND OAKS, Calif.--(BUSINESS WIRE)--June 24, 2004--Amgen Inc. (Nasdatuck-6/24/2004
356Seattle Genetics and CuraGen Announce Antibody-Drug Conjugate -- ADC -- Agreemennigel bates-6/22/2004
355454 Life Sciences Receives $2.4 million NIH Grant for Next Generation Whole Genonigel bates-5/19/2004
354Thanks, Tuck. I'm in this morning with very small initial position and willAllan Harris-3/30/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News